{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T04:09:22Z","timestamp":1746850162988,"version":"3.40.5"},"reference-count":51,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ejso.2025.109675","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T16:51:44Z","timestamp":1738601504000},"page":"109675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic value of preoperative serum C-reactive protein level for survival in mucinous appendix cancer treated with complete CRS\/HIPEC"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4772-5477","authenticated-orcid":false,"given":"Andrei","family":"Nikiforchin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4132-9489","authenticated-orcid":false,"given":"Armando","family":"Sardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3376-3827","authenticated-orcid":false,"given":"Mary Caitlin","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9778-4208","authenticated-orcid":false,"given":"Sergei","family":"Iugai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9704-6547","authenticated-orcid":false,"given":"Ekaterina","family":"Baron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe","family":"Lopez-Ramirez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3921-7210","authenticated-orcid":false,"given":"Vladislav","family":"Kovalik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5065-1416","authenticated-orcid":false,"given":"Luis Felipe","family":"Falla-Zuniga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5877-0521","authenticated-orcid":false,"given":"Philipp","family":"Barakat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Nieroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6151-5660","authenticated-orcid":false,"given":"Vadim","family":"Gushchin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ejso.2025.109675_bib1","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","article-title":"Cancer-related inflammation and treatment effectiveness","volume":"15","author":"Diakos","year":"2014","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2025.109675_bib2","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ejso.2025.109675_bib3","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0002-9440(10)64211-3","article-title":"Pseudomyxoma peritonei is a disease of MUC2-expressing goblet cells","volume":"161","author":"O'Connell","year":"2002","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.ejso.2025.109675_bib4","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s000110050576","article-title":"Eisenbl\u00e4tter R., et al. Proinflammatory cytokines trigger MUC gene expression and mucin release in the intestinal cancer cell line LS180","volume":"49","author":"Enss","year":"2000","journal-title":"Inflamm Res"},{"issue":"7","key":"10.1016\/j.ejso.2025.109675_bib5","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/jso.23146","article-title":"Mucin as a therapeutic target in pseudomyxoma peritonei","volume":"106","author":"Choudry","year":"2012","journal-title":"J Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2025.109675_bib6","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1245\/s10434-013-3261-6","article-title":"Pseudomyxoma peritonei: inflammatory responses in the peritoneal microenvironment","volume":"21","author":"Lohani","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2025.109675_bib7","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/sj.bjc.6603185","article-title":"Horgan P.G.,et al. The presence of a systemic inflammatory response predicts poorer survival in patients receiving adjuvant 5-FU chemotherapy following potentially curative resection for colorectal cancer","volume":"94","author":"Crozier","year":"2006","journal-title":"Br J Cancer"},{"issue":"7","key":"10.1016\/j.ejso.2025.109675_bib8","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/jso.24415","article-title":"Isoniemi H., et al. The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C-reactive protein (CRP) is a strong negative prognostic biomarker","volume":"114","author":"K\u00f8stner","year":"2016","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejso.2025.109675_bib9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2147\/TCRM.S70954","article-title":"Prognostic role of serum C-reactive protein in esophageal cancer: a systematic review and meta-analysis","volume":"11","author":"Huang","year":"2015","journal-title":"Therapeut Clin Risk Manag"},{"issue":"8","key":"10.1016\/j.ejso.2025.109675_bib10","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.7314\/APJCP.2014.15.8.3369","article-title":"Prognostic significance of C-reactive protein in urological cancers: a systematic review and meta-analysis","volume":"15","author":"Dai","year":"2014","journal-title":"Asian Pac J Cancer Prev APJCP"},{"issue":"7","key":"10.1016\/j.ejso.2025.109675_bib11","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1245\/s10434-019-08117-w","article-title":"Predicting aborted hyperthermic intraperitoneal chemotherapy (AHIPEC) with preoperative tumor and inflammatory markers in potentially resectable appendiceal cancer patients with peritoneal carcinomatosis","volume":"27","author":"Baron","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"13","key":"10.1016\/j.ejso.2025.109675_bib12","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1245\/s10434-020-08535-1","article-title":"Impact of mucin cellularity and distribution on survival in newly diagnosed patients with low-grade appendiceal mucinous neoplasm treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"27","author":"Nikiforchin","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2025.109675_bib13","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/SLA.0b013e3182602ad2","article-title":"Inflammatory markers in blood and serum tumor markers predict survival in patients with epithelial appendiceal neoplasms undergoing surgical cytoreduction and intraperitoneal chemotherapy","volume":"256","author":"Chua","year":"2012","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ejso.2025.109675_bib14","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ejso.2016.10.009","article-title":"The modified Glasgow prognosis score predicts for overall and disease-free survival following cytoreductive surgery and HIPEC in patients with pseudomyxoma peritonei of appendiceal origin","volume":"43","author":"Tan","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.109675_bib15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0000000000000535","article-title":"A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia","volume":"40","author":"Carr","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"13","key":"10.1016\/j.ejso.2025.109675_bib16","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1245\/s10434-014-3869-1","article-title":"Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"21","author":"Jimenez","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"20","key":"10.1016\/j.ejso.2025.109675_bib17","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","article-title":"Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Chua","year":"2012","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.109675_bib18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1470-2045(05)70539-8","article-title":"New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?","volume":"7","author":"Sugarbaker","year":"2006","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2025.109675_bib19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3322\/caac.21388","article-title":"The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA A Cancer J Clin"},{"issue":"6","key":"10.1016\/j.ejso.2025.109675_bib20","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1245\/s10434-021-11233-1","article-title":"Iterative cytoreduction and hyperthermic intraperitoneal chemotherapy for recurrent mucinous adenocarcinoma of the appendix","volume":"29","author":"Lopez-Ramirez","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2025.109675_bib21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/DCR.0000000000001003","volume":"61","author":"Paul","year":"2018","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ejso.2025.109675_bib22","unstructured":"Jacquet P, Stephens AD, Averbach AM, et al. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated lntraoperative lntraperitoneal chemotherapy. doi:10.1002\/(SICI)1097-0142(19960615)77:12."},{"issue":"2","key":"10.1016\/j.ejso.2025.109675_bib23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.ejso.2025.109675_bib24","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1002\/cncr.32881","article-title":"The Chicago Consensus on peritoneal surface malignancies: management of appendiceal neoplasms","volume":"126","author":"Schuitevoerder","year":"2020","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ejso.2025.109675_bib25","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1245\/s10434-021-10669-9","article-title":"Outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy with and without diaphragmatic resection in patients with peritoneal metastases","volume":"29","author":"Nikiforchin","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2025.109675_bib26","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/sim.3569","article-title":"Choosing an optimal method to combine P-values","volume":"28","author":"Won","year":"2009","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.ejso.2025.109675_bib27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B Stat Methodol"},{"issue":"1","key":"10.1016\/j.ejso.2025.109675_bib30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2217\/fon.09.136","article-title":"Role of systemic inflammatory response in predicting survival in patients with primary operable cancer","volume":"6","author":"Roxburgh","year":"2010","journal-title":"Future Oncol"},{"issue":"56","key":"10.1016\/j.ejso.2025.109675_bib31","doi-asserted-by":"crossref","first-page":"96048","DOI":"10.18632\/oncotarget.21647","article-title":"Inflammatory biomarkers in metastatic colorectal cancer: prognostic and predictive role beyond the first line setting","volume":"8","author":"Riedl","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.ejso.2025.109675_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju124","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis","volume":"106","author":"Templeton","year":"2014","journal-title":"JNCI: J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.ejso.2025.109675_bib33","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jviscsurg.2020.08.001","article-title":"Preoperative inflammation is an independent factor of worse prognosis after colorectal cancer surgery","volume":"158","author":"Bert","year":"2021","journal-title":"J Vis Surg"},{"issue":"6","key":"10.1016\/j.ejso.2025.109675_bib34","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/bjc.2014.90","article-title":"Cancer and systemic inflammation: treat the tumour and treat the host","volume":"110","author":"Roxburgh","year":"2014","journal-title":"Br J Cancer"},{"issue":"13","key":"10.1016\/j.ejso.2025.109675_bib35","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.3390\/cancers15133426","article-title":"Appendiceal mucinous neoplasms: from clinic to pathology and prognosis","volume":"15","author":"Gonz\u00e1lez Bay\u00f3n","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ejso.2025.109675_bib36","doi-asserted-by":"crossref","unstructured":"McClellan J.L., Mark Davis J., Steiner J.L., Enos R.T., Jung S.H., Carson J.A., et al. Inking tumor-associated macrophages, inflammation, and intestinal tumorigenesis: role of MCP-1. Am J Physiol Gastrointest Liver Physiol. 2012 303(10):1087\u20131095. doi:10.1152\/ajpgi.00252.2012.","DOI":"10.1152\/ajpgi.00252.2012"},{"issue":"APR","key":"10.1016\/j.ejso.2025.109675_bib37","article-title":"Role of C-reactive protein at sites of inflammation and infection","volume":"9","author":"Sproston","year":"2018","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.ejso.2025.109675_bib38","doi-asserted-by":"crossref","first-page":"7848","DOI":"10.1245\/s10434-023-14145-4","article-title":"Patterns of recurrence in appendix cancer after complete cytoreduction and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Nikiforchin","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2025.109675_bib39","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jamcollsurg.2012.04.023","article-title":"Outcomes of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy","volume":"215","author":"Votanopoulos","year":"2012","journal-title":"J Am Coll Surg"},{"issue":"5","key":"10.1016\/j.ejso.2025.109675_bib40","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ctrv.2012.08.003","article-title":"The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer","volume":"39","author":"McMillan","year":"2013","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"10.1016\/j.ejso.2025.109675_bib41","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/bjs5.50134","article-title":"Factors influencing long-term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei originating from appendiceal neoplasms","volume":"3","author":"van Eden","year":"2019","journal-title":"BJS Open"},{"issue":"4","key":"10.1016\/j.ejso.2025.109675_bib42","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/jso.26371","article-title":"Surgical and oncological outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a nonacademic center: 25-year experience","volume":"123","author":"Nikiforchin","year":"2021","journal-title":"J Surg Oncol"},{"issue":"31","key":"10.1016\/j.ejso.2025.109675_bib43","article-title":"Development and validation of prognostic nomograms for pseudomyxoma peritonei patients after surgery: a population-based study","volume":"99","author":"Chen","year":"2020","journal-title":"Medicine (United States)"},{"issue":"5","key":"10.1016\/j.ejso.2025.109675_bib44","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/jamasurg.2023.0112","article-title":"Development and validation of nomograms to predict survival in patients undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendiceal origin","volume":"158","author":"Chandrakumaran","year":"2023","journal-title":"JAMA Surg"},{"issue":"4","key":"10.1016\/j.ejso.2025.109675_bib45","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","article-title":"Nomograms in oncology: more than meets the eye","volume":"16","author":"Balachandran","year":"2015","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2025.109675_bib46","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/sj.bjc.6604997","article-title":"Preoperative systemic inflammation predicts postoperative infectious complications in patients undergoing curative resection for colorectal cancer","volume":"100","author":"Moyes","year":"2009","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.ejso.2025.109675_bib47","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s00384-016-2620-8","article-title":"Preoperative inflammation increases the risk of infection after elective colorectal surgery: results from a prospective cohort","volume":"31","author":"De Magistris","year":"2016","journal-title":"Int J Colorectal Dis"},{"issue":"9","key":"10.1016\/j.ejso.2025.109675_bib48","doi-asserted-by":"crossref","first-page":"916","DOI":"10.3390\/jpm14090916","article-title":"The importance of preoperative NLR, PLR, and MPV values in predicting the risk of complications in colorectal peritoneal carcinomatosis","volume":"14","author":"\u00d6zcan","year":"2024","journal-title":"J Personalized Med"},{"issue":"2","key":"10.1016\/j.ejso.2025.109675_bib49","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/SLA.0b013e31825704e3","article-title":"Identification of a subgroup of patients at highest risk for complications after surgical cytoreduction and hyperthermic intraperitoneal chemotherapy","volume":"256","author":"Baratti","year":"2012","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.ejso.2025.109675_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-9-71","article-title":"Secreted mucins in pseudomyxoma peritonei: pathophysiological significance and potential therapeutic prospects","volume":"9","author":"Amini","year":"2014","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.ejso.2025.109675_bib51","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.canlet.2005.12.013","article-title":"COX-2 expression in pseudomyxoma peritonei","volume":"244","author":"Gatalica","year":"2006","journal-title":"Cancer Lett"},{"issue":"5","key":"10.1016\/j.ejso.2025.109675_bib52","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1245\/s10434-012-2242-5","article-title":"Chronic anti-inflammatory drug therapy inhibits gel-forming mucin production in a murine xenograft model of human pseudomyxoma peritonei","volume":"19","author":"Choudry","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.109675_bib53","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/COC.0000000000000878","article-title":"Celecoxib and myrtol A novel therapy for recurrent appendiceal mucinous neoplasms with extensive peritoneal dissemination","volume":"45","author":"Vierra","year":"2022","journal-title":"Am J Clin Oncol: Cancer Clin Trials"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325001039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325001039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T15:51:52Z","timestamp":1746805912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798325001039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0748798325001039"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2025.109675","relation":{},"ISSN":["0748-7983"],"issn-type":[{"type":"print","value":"0748-7983"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of preoperative serum C-reactive protein level for survival in mucinous appendix cancer treated with complete CRS\/HIPEC","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2025.109675","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109675"}}